<mods:mods version="3.3" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-3.xsd" xmlns:mods="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><mods:titleInfo><mods:title>PSIXOSTIMULYATORLAR.DEPRESSIYAGA QARSHI VOSITALAR.</mods:title></mods:titleInfo><mods:name type="personal"><mods:namePart type="given">Kibriyeva</mods:namePart><mods:namePart type="family">Maxfirat</mods:namePart><mods:role><mods:roleTerm type="text">author</mods:roleTerm></mods:role></mods:name><mods:name type="personal"><mods:namePart type="given">Nosoatova</mods:namePart><mods:namePart type="family">Jasmina</mods:namePart><mods:role><mods:roleTerm type="text">author</mods:roleTerm></mods:role></mods:name><mods:abstract>Ushbu ilmiy maqolada markaziy nerv tizimiga (MNT) ta’sir etuvchi ikki muhim guruh - psixostimulyatorlar va antidepressantlarning farmakologik xususiyatlari, ta’sir mexanizmlari hamda klinik amaliyotdagi o‘rni tahlil qilinadi. Tadqiqot davomida neyromediatorlar (dofamin, noradrenalin, serotonin) almashinuvining buzilishi bilan bog‘liq patologiyalarni korreksiya qilishda ushbu vositalarning ahamiyati yoritilgan</mods:abstract><mods:originInfo><mods:dateIssued encoding="iso8601">2026-06-13</mods:dateIssued></mods:originInfo><mods:originInfo><mods:publisher>Research Science and Innovation House</mods:publisher></mods:originInfo><mods:genre>Maqola</mods:genre></mods:mods>